logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-5. Characteristics of all clients entering treatment: demographics and primary drug at treatment in 2006 or most recent year available [see all tables in this series...]

Part (iv) Demographics of all women entering treatment

CountryYearMean age% Age <25% Age 35+
Bulgaria200624583
Czech Republic200623655
Denmark2006333040
Germany2006313532
Ireland2006283715
Greece2006293718
Spain(1)2005322336
France2006294325
Italy(2)2006322839
Cyprus2006274616
Latvia(3)2006245211
Lithuania2006312527
Luxembourg2006283724
Hungary2006283138
Malta2006254710
Netherlands2006322446
Austria(4)2006256012
Poland(1)2005353645
Portugal(3)2006312433
Romania2006353739
Slovenia(5)200424644
Slovakia2006275218
Finland2006265511
Sweden2006343241
United Kingdom(6)2006303327
Turkey2006274320

Notes:

 Data were not available for: Belgium, Estonia, Norway. 

 (1) Last data available refer to 2005. 

 (2) Until 2004, ‘all clients’ reported clients continuing in or entering treatment in reported year; since 2005 data are conformant with the TDI protocol. 

 (3) Data by gender refer to first treatments. 

 (4) Up to 2005 data only refer to clients in substitution treatment, using opioids as primary drug. Since 2006, new data collection has been conducted. 

 (5) Last data available refer to 2004. It includes data for outpatient clients and clients treated in prison. Data for outpatient clients was validated, however data collection for prison clients was still in the process of development, thus figures are underestimated. With effect from next year the process of data validation for prison clients will be implemented.  

 (6) Data relate to the period from 1 April 2005 to 31 March 2006 for the UK. 

 See also ‘General notes for interpreting data’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2007 — Standard table 3. See Table TDI-1 for details on sources. 

(see the help page for information about formats etc.)

Page last updated: Monday, 14 July 2008